Menu
Log In Sign Up
Article

peptide y YY causes intestinal constriction inhibiting jejunal and colonic motility

Published October Oct 17, 2026 12:56 PM

In the landscape of biochemical research, few molecules have garnered as much interest for their role in signaling as peptide y. As someone who has spent years documenting personal experie Y2 receptor agonist, released from the body's gastrointestinal tract in proportion to caloric intake, that significantly decreases appetite and reduces food Read more nces with various research compounds, I have found that understanding the structural and functional nuances of these chains is essential for anyone interested in the field of peptide study.

Understanding Peptide Y: A Structural Overview

At its core, peptide y (commonly referred to as PYY) is a short, 36-amino acid peptide that serves as a fascinating subject for laboratory observation. It is primarily synthesized and released by the enteroendocrine L-cells located in the lining of the body’s ileum and colon.

From my perspective, the most intriguing aspect of this compound is that it is a 36-amino acid, straight-chain polypeptide, often studied alongside GLP-1 due to their co-localization within the gastrointestinal tract. Research confirms that it was initially isolated from porcine intestinal extracts and named for the tyrosine residues at its C- and N-termini. When looking at specific variants Nov 10, 2018—Peptide YY isa short (36-amino acid) peptide releasedfrom cells in the ileum and colon in response to feeding.Read more , such as human PYY (3-36), we see a molecule with a molecular weight of 4049.71, which is often evaluated for its high purity—f Peptide YY (human) requently reaching 96% or greater in laboratory-grade samples.

Mechanism and Biological Signaling

The utility of this molecule lies in its status as a potent neuropeptide Y2 receptor agonist. By interacting with various receptors Peptide YY | Hormones , including Y1, Y2, Y4, and Y5, it influences a cascade of physiological processes.

My interest in this peptide stems from its role as a peptide hormone released by the gut in response to food intake. It is often described Mar 3, 2026—Peptide YY inhibits transcription and replication of hepatitis B virusby suppressing promoter/enhancer activity. Structural basis for Y2 Read more as an "ileal brake," a mechanism where the gut s Peptide YY in Type 2 Diabetes: A Complementary Gut ignals its status to the rest of the system. Scientists note that PYY is anorexigenic and inhibits feeding stimuli after a meal, which is why it is frequently utilized in settings investigating appetite regulation and gut motility.

Key Characteristics and Research Observations

When examining the literature and community discussions, several points stand out regarding its function:

* Intestinal Dynamics: The substance is known to cause intestinal constriction, inhibiting jejunal and colonic motility. This makes it a powerful inhibitor of intestinal secretion.

* Pancreatic Influence: Beyond its gut-centric roles, it also inhibits pancreatic bicarbonate and protein secretion, highlighting its systemic reach.

* Receptor Selectivity: As a Y2 selective agonist, its IC50 values (0.11 nM for Y2 receptors) demonstrate a high affinity that is critical for precise experimental work.

* Broader Interactions: Beyond appetite, researchers have explored its role in insulin secretion and even its ability to suppress promoter/enhancer activity in specific viral contexts, such as the hepatitis B virus.

Insights for the Research Enthusiast

For those exploring the "how-to" of this subject, it is important to distinguish between the various forms. Whether you are reading about the full 1-36 sequence or the shorter 3-36 fragment, the primary focus remains on its role as a signaling molecule.

Many in the research community frequently co PYY is anorexigenic and inhibits feeding stimuli after a meal, thus preventing excessive energy intake.Read more mpare it to Neuropeptide Y (NPY), which acts directly in the periphery on fat tissue and mediates metabolic responses. While NPY and PYY share structural similarities as members of the pancreatic polypeptide (PP) family, their specific roles in the central and peripheral nervous systems differ significantly.

Conclusion on Personal Application

My experience with such compounds has taught me that consistency and by MH Tschöp·2007·Cited by 8—Neuropeptide Y acts directly in the periphery on fat tissueand mediates stress-induced obesity and metabolic syndrome. Nat Med 13: 803–811, Read more purity are paramount. Because PYY is a hormone made in the small intestine and acts as a key regulator, handling it requires an understanding of its sensitivity. When stored correctly—usually in a lyophilized state—it can remain stable for up to six months.

Whether you are investigating its role in inhibiting feeding stimuli or its potential as a Y2 receptor agonist, the scientific depth of peptide y provides a rich field for exploration. Always ensure your sources provide verifiable purity reports, as the integrity of the 36-amino acid chain is vital for any meaningful observation.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.